English

The Norwegian Biotechnology Advisory Board

The Norwegian Biotechnology Advisory Board is an independent body consisting of 15 members appointed by the Norwegian government. Each member has a background and/or education which makes him/her competent to discuss questions regarding modern biotechnology. The main tasks of the Norwegian Biotechnology Advisory Board is to evaluate the social and ethical consequences of modern biotechnology and to discuss usage which promotes sustainable development.

The Norwegian Biotechnology Advisory Board has approximately ten regular board meetings and organises several public conferences annually.

The secretariat of the Norwegian Biotechnology Advisory Board has seven employees assisting and coordinating the board.

The Norwegian Biotechnology Advisory Board publishes the free, quarterly journal GENialt in Norwegian. In addition it makes background information available on various topics regarding modern biotechnology.

For further information, please contact the secretariat of the Norwegian Biotechnology Advisory Board at the phone number or address below.

 

Discussion paper 2014

Herbicide-resistant genetically modified plants and sustainability

 

Brochure 2010

Preimplantation Genetic Diagnosis (pdf, 26.04.2010)

 

Discussion papers

«Gene medication or genetic modification? The devil is in the details», Foss, G.S & Rogne S.

Sustainability, benefit to the community and ethics in the assessment of genetically modified organisms

Regulation of DNA vaccines and gene therapy on animals

Siden ble opprettet: 25.08.2010. Siden ble oppdatert: 24.11.2015

© 2016 Bioteknologirådet. | Design: Tank - Utviklet av: Spekter